Results for tag: "Liquid Nitrogen Cryopreservation"

In the context of biotechnology, the liquid nitrogen cryopreservation market encompasses the technologies and services related to the long-term storage of biological materials at cryogenic temperatures. Liquid nitrogen is employed to maintain samples at around -196 degrees Celsius, a temperature at which biological activity, including the enzymatic reactions that lead to cell degradation, is effectively halted. This market serves a critical function in various biotechnology applications including the preservation of cell cultures, tissues, and biological samples for research and medical use, such genes, sperm, eggs, and other cellular materials for assisted reproductive technology, and the preservation of biological samples for forensic analysis. The process of cryopreservation requires specialized equipment such as cryo storage tanks, cryogenic freezers, cryo containers, and associated accessories that facilitate the controlled-rate freezing necessary for the prevention of ice crystal formation, which can damage biological specimens. It also includes the software and inventory systems used to monitor and manage the stored materials. This market is closely aligned with advances in cell biology, regenerative medicine, and the broader pharmaceutical and life sciences industries. Prominent companies within the liquid nitrogen cryopreservation market include Thermo Fisher Scientific, Merck KGaA, and BioLife Solutions. Each of these companies provides products and services that address different needs within the cryopreservation workflow, from cryoprotectants and storage systems to transportation and monitoring solutions for the secure handling of cryogenically preserved biological materials. Show Less Read more